Ameriprise Financial Inc. decreased its position in Amdocs Ltd. (NASDAQ:DOX) by 2.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 287,034 shares of the company’s stock after selling 7,726 shares during the period. Ameriprise Financial Inc. owned about 0.19% of Amdocs worth $16,574,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of DOX. Boston Partners boosted its position in shares of Amdocs by 7.5% in the second quarter. Boston Partners now owns 6,827,727 shares of the company’s stock worth $394,096,000 after buying an additional 476,604 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in shares of Amdocs by 0.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,187,025 shares of the company’s stock worth $252,980,000 after buying an additional 22,569 shares in the last quarter. Investec Asset Management LTD boosted its position in shares of Amdocs by 4.8% in the first quarter. Investec Asset Management LTD now owns 3,269,460 shares of the company’s stock worth $197,541,000 after buying an additional 150,828 shares in the last quarter. State Street Corp boosted its position in shares of Amdocs by 2.8% in the first quarter. State Street Corp now owns 1,995,422 shares of the company’s stock worth $120,562,000 after buying an additional 53,565 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Amdocs by 48.3% in the first quarter. Wellington Management Group LLP now owns 1,876,826 shares of the company’s stock worth $113,397,000 after buying an additional 610,839 shares in the last quarter. 89.63% of the stock is owned by institutional investors and hedge funds.
Shares of Amdocs Ltd. (NASDAQ:DOX) traded up 0.29% during mid-day trading on Thursday, hitting $59.22. 750,852 shares of the stock were exchanged. Amdocs Ltd. has a 12-month low of $50.06 and a 12-month high of $61.33. The stock has a market capitalization of $8.81 billion, a P/E ratio of 22.39 and a beta of 0.68. The stock’s 50 day moving average price is $59.51 and its 200-day moving average price is $58.20.
Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.87 by $0.03. Amdocs had a return on equity of 14.59% and a net margin of 10.93%. The business had revenue of $930 million for the quarter, compared to analysts’ expectations of $928.81 million. During the same period in the previous year, the business posted $0.84 EPS. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. On average, equities research analysts expect that Amdocs Ltd. will post $3.57 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 21st. Stockholders of record on Friday, September 30th will be given a dividend of $0.195 per share. This represents a $0.78 annualized dividend and a dividend yield of 1.32%. The ex-dividend date is Wednesday, September 28th. Amdocs’s dividend payout ratio is presently 29.32%.
DOX has been the subject of several research analyst reports. Citigroup Inc. upped their price target on shares of Amdocs from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, July 27th. JPMorgan Chase & Co. upped their price target on shares of Amdocs from $61.00 to $64.00 and gave the company a “neutral” rating in a report on Wednesday, July 27th. Jefferies Group upped their price target on shares of Amdocs from $56.00 to $58.00 and gave the company a “hold” rating in a report on Tuesday, August 2nd. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $65.00 price target on shares of Amdocs in a report on Thursday, September 15th. Finally, Zacks Investment Research upgraded shares of Amdocs from a “hold” rating to a “buy” rating and set a $64.00 price target for the company in a report on Tuesday, July 5th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $63.13.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Receive News & Ratings for Amdocs Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.